- Home
- CGAU vs STAA Comparison
CGAU vs STAA Comparison
Compare CGAU & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGAU
- STAA
- Stock Information
- Founded
- CGAU 2002
- STAA 1982
- Country
- CGAU Canada
- STAA United States
- Employees
- CGAU N/A
- STAA N/A
- Industry
- CGAU Precious Metals
- STAA Ophthalmic Goods
- Sector
- CGAU Basic Materials
- STAA Health Care
- Exchange
- CGAU Nasdaq
- STAA Nasdaq
- Market Cap
- CGAU 1.3B
- STAA 1.2B
- IPO Year
- CGAU N/A
- STAA N/A
- Fundamental
- Price
- CGAU $6.25
- STAA $17.60
- Analyst Decision
- CGAU Buy
- STAA Buy
- Analyst Count
- CGAU 2
- STAA 9
- Target Price
- CGAU $11.00
- STAA $30.71
- AVG Volume (30 Days)
- CGAU 1.1M
- STAA 983.9K
- Earning Date
- CGAU 05-13-2025
- STAA 05-06-2025
- Dividend Yield
- CGAU 3.22%
- STAA N/A
- EPS Growth
- CGAU N/A
- STAA N/A
- EPS
- CGAU 0.35
- STAA N/A
- Revenue
- CGAU $1,214,503,000.00
- STAA $313,901,000.00
- Revenue This Year
- CGAU N/A
- STAA N/A
- Revenue Next Year
- CGAU $2.75
- STAA $25.89
- P/E Ratio
- CGAU $17.63
- STAA N/A
- Revenue Growth
- CGAU 10.92
- STAA N/A
- 52 Week Low
- CGAU $5.46
- STAA $13.50
- 52 Week High
- CGAU $7.82
- STAA $52.68
- Technical
- Relative Strength Index (RSI)
- CGAU 51.97
- STAA 44.92
- Support Level
- CGAU $6.13
- STAA $17.34
- Resistance Level
- CGAU $6.54
- STAA $18.24
- Average True Range (ATR)
- CGAU 0.18
- STAA 0.77
- MACD
- CGAU 0.03
- STAA 0.10
- Stochastic Oscillator
- CGAU 56.25
- STAA 53.24
About CGAU Centerra Gold Inc.
Centerra Gold Inc a gold mining and exploration company engaged in the operation, exploration, development, and acquisition of gold properties in Asia, North America, and other markets world-wide. The company reportable operating segments are Oksut; Mount; and Milligan Molybdenum. It derives maximum revenue from Oksut segment. Geographically, it operates in Turkey, United States, Canada and Other.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.